These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 38264683)

  • 1. Molecular imaging of tumour-associated pathological biomarkers with smart nanoprobe: From "Seeing" to "Measuring".
    Zhang P; Li W; Liu C; Qin F; Lu Y; Qin M; Hou Y
    Exploration (Beijing); 2023 Dec; 3(6):20230070. PubMed ID: 38264683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Smart" Nanoprobes for Visualization of Tumor Microenvironments.
    Ma T; Zhang P; Hou Y; Ning H; Wang Z; Huang J; Gao M
    Adv Healthc Mater; 2018 Oct; 7(20):e1800391. PubMed ID: 29999250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activable Multi-Modal Nanoprobes for Imaging Diagnosis and Therapy of Tumors.
    Yang Y; Yue S; Qiao Y; Zhang P; Jiang N; Ning Z; Liu C; Hou Y
    Front Chem; 2020; 8():572471. PubMed ID: 33912535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Design of Abnormal Microenvironment Responsive MRI Nanoprobe and Its Application.
    Wang A; Han X; Qi W; Du S; Jiang Z; Tang X
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34067989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-stimuli responsive smart nanoprobe for precise diagnosis and synergistic multi-modalities therapy of superficial squamous cell carcinoma.
    Zhang P; Cui Y; Wang J; Cheng J; Zhu L; Liu C; Yue S; Pang R; Guan J; Xie B; Zhang N; Qin M; Jing L; Hou Y; Lan Y
    J Nanobiotechnology; 2023 Jan; 21(1):4. PubMed ID: 36597067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nontoxic Fluorescent Nanoprobes for Multiplexed Detection and 3D Imaging of Tumor Markers in Breast Cancer.
    Sokolov P; Nifontova G; Samokhvalov P; Karaulov A; Sukhanova A; Nabiev I
    Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ratiometric optical nanoprobes enable accurate molecular detection and imaging.
    Huang X; Song J; Yung BC; Huang X; Xiong Y; Chen X
    Chem Soc Rev; 2018 Apr; 47(8):2873-2920. PubMed ID: 29568836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances and opportunities in proteomic analyses of tumour heterogeneity.
    Bateman NW; Conrads TP
    J Pathol; 2018 Apr; 244(5):628-637. PubMed ID: 29344964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET imaging for the quantification of biologically heterogeneous tumours: measuring the effect of relative position on image-based quantification of dose-painting targets.
    McCall KC; Barbee DL; Kissick MW; Jeraj R
    Phys Med Biol; 2010 May; 55(10):2789-806. PubMed ID: 20413832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Cooperatively Activatable DNA Nanoprobe for Cancer Cell-Selective Imaging of ATP.
    Zhou Y; Zou L; Li G; Shi T; Yu S; Wang F; Liu X
    Anal Chem; 2021 Oct; 93(41):13960-13966. PubMed ID: 34605640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Transistor-like pH Nanoprobe for Tumour Detection and Image-guided Surgery.
    Zhao T; Huang G; Li Y; Yang S; Ramezani S; Lin Z; Wang Y; Ma X; Zeng Z; Luo M; de Boer E; Xie XJ; Thibodeaux J; Brekken RA; Sun X; Sumer BD; Gao J
    Nat Biomed Eng; 2016; 1():. PubMed ID: 28966871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-associated Fibroblasts in Bladder Cancer: Origin, Biology, and Therapeutic Opportunities.
    Caramelo B; Zagorac S; Corral S; Marqués M; Real FX
    Eur Urol Oncol; 2023 Aug; 6(4):366-375. PubMed ID: 36890105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-Activatable Clinical Nanoprobe for Cancer Imaging.
    Reichel D; Tripathi M; Butte P; Saouaf R; Perez JM
    Nanotheranostics; 2019; 3(2):196-211. PubMed ID: 31183314
    [No Abstract]   [Full Text] [Related]  

  • 14. Translating imaging traits of mass-forming intrahepatic cholangiocarcinoma into the clinic: From prognostic to therapeutic insights.
    Ji GW; Xu Q; Jiao CY; Lu M; Xu ZG; Zhang B; Yang Y; Wang K; Li XC; Wang XH
    JHEP Rep; 2023 Oct; 5(10):100839. PubMed ID: 37663120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An acidic pH/reduction dual-stimuli responsive nanoprobe for enhanced CT imaging of tumours in vivo.
    Wang A; Yin L; He L; Xia H; Chen F; Zhao M; Ding J; Shi H
    Nanoscale; 2018 Nov; 10(43):20126-20130. PubMed ID: 30376027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The challenge of intratumour heterogeneity in precision medicine.
    Seoane J; De Mattos-Arruda L
    J Intern Med; 2014 Jul; 276(1):41-51. PubMed ID: 24661605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of liver tumour response by imaging.
    Gregory J; Dioguardi Burgio M; Corrias G; Vilgrain V; Ronot M
    JHEP Rep; 2020 Jun; 2(3):100100. PubMed ID: 32514496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delineating spatial cell-cell interactions in the solid tumour microenvironment through the lens of highly multiplexed imaging.
    Cohn DE; Forder A; Marshall EA; Vucic EA; Stewart GL; Noureddine K; Lockwood WW; MacAulay CE; Guillaud M; Lam WL
    Front Immunol; 2023; 14():1275890. PubMed ID: 37936700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smart Self-Assembled Organic Nanoprobe for Protein-Specific Detection: Design, Synthesis, Application, and Mechanism Studies.
    Gao T; Yang S; Cao X; Dong J; Zhao N; Ge P; Zeng W; Cheng Z
    Anal Chem; 2017 Sep; 89(18):10085-10093. PubMed ID: 28828856
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.